Sterling Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.5K Sell
152
-8
-5% -$3.69K ﹤0.01% 1450
2026
Q1
$76.8K Hold
160
﹤0.01% 1482
2025
Q4
$89.9K Buy
160
+126
+371% +$71.5K ﹤0.01% 1568
2025
Q3
$17.5K Sell
34
-1
-3% -$437 ﹤0.01% 2210
2025
Q2
$11K Sell
35
-51
-59% -$15.3K ﹤0.01% 2067
2025
Q1
$26.2K Sell
86
-325
-79% -$109K ﹤0.01% 1579
2024
Q4
$137K Sell
411
-51
-11% -$17.3K ﹤0.01% 1366
2024
Q3
$154K Buy
+462
New +$176K ﹤0.01% 1316
2019
Q3
$1.7M Buy
20,206
+14,496
+254% +$1.1M 0.02% 452
2019
Q2
$374K Hold
5,710
﹤0.01% 784
2019
Q1
$337K Sell
5,710
-6,590
-54% -$394K ﹤0.01% 774
2018
Q4
$651K Buy
+12,300
New +$675K 0.01% 696

Other funds holding MEDP

Sterling Capital Management's MEDP Position: Q2 2026 in Review

Sterling Capital Management reduced its Medpace (MEDP) stake by 5% in Q2 2026, selling an estimated $3.69K and leaving 152 shares worth $80.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Sterling Capital Management first reported a position in MEDP in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.7M in Q3 2019. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Sterling Capital Management held 152 shares of Medpace worth $80.5K as of Q2 2026.
  • Sterling Capital Management sold 8 Medpace shares in Q2 2026, an estimated $3.69K.
  • Medpace made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1450 holding.
  • Sterling Capital Management first reported a position in Medpace in Q4 2018 and has held it in 12 quarters since.
  • Sterling Capital Management's Medpace position peaked at $1.7M in Q3 2019.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.